Gamma Investing LLC Fennec Pharmaceuticals Inc. Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 113 shares of FENC stock, worth $950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113
Previous 110
2.73%
Holding current value
$950
Previous $670,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding FENC
# of Institutions
71Shares Held
13.9MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$34.3 Million0.72% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$20.2 Million33.54% of portfolio
-
Solas Capital Management, LLC Darien, CT2.25MShares$18.9 Million9.62% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$9.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA965KShares$8.11 Million0.0% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $219M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...